Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics

RNA interference (RNAi)-based therapeutics have been used to silence the expression of targeted pathological genes. Small interfering RNA (siRNAs) and microRNA (miRNAs) inhibitor have performed this function. However, short half-life, poor cellular uptake, and nonspecific distribution of small RNAs...

Descripción completa

Detalles Bibliográficos
Autores principales: Gentile, Emanuela, Oba, Taro, Lin, Jing, Shao, Ruping, Meng, Feng, Cao, Xiaobo, Lin, Heather Y., Mourad, Majidi, Pataer, Apar, Baladandayuthapani, Veerabhadran, Cai, Dong, Roth, Jack A., Ji, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564640/
https://www.ncbi.nlm.nih.gov/pubmed/28637023
http://dx.doi.org/10.18632/oncotarget.18421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564640/
https://www.ncbi.nlm.nih.gov/pubmed/28637023
http://dx.doi.org/10.18632/oncotarget.18421

Ejemplares similares